Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome
- PMID: 37681921
- PMCID: PMC10487183
- DOI: 10.3390/cells12172189
Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a prevalent gynecological and endocrine disorder that results in irregular menstruation, incomplete follicular development, disrupted ovulation, and reduced fertility rates among affected women of reproductive age. While these symptoms can be managed through appropriate medication and lifestyle interventions, both etiology and treatment options remain limited. Here we provide a comprehensive overview of the latest advancements in cellular approaches utilized for investigating the pathophysiology of PCOS through in vitro cell models, to avoid the confounding systemic effects such as in vitro fertilization (IVF) therapy. The primary objective is to enhance the understanding of abnormalities in PCOS-associated folliculogenesis, particularly focusing on the aberrant roles of granulosa cells and other relevant cell types. Furthermore, this article encompasses analyses of the mechanisms and signaling pathways, microRNA expression and target genes altered in PCOS, and explores the pharmacological approaches considered as potential treatments. By summarizing the aforementioned key findings, this article not only allows us to appreciate the value of using in vitro cell models, but also provides guidance for selecting suitable research models to facilitate the identification of potential treatments and understand the pathophysiology of PCOS at the cellular level.
Keywords: androgen receptor; folliculogenesis; granulosa cells; hyperandrogenism; polycystic ovary syndrome.
Conflict of interest statement
The authors declare no conflict interests.
Figures


Similar articles
-
Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.Syst Biol Reprod Med. 2017 Jun;63(3):150-161. doi: 10.1080/19396368.2017.1296046. Epub 2017 Mar 27. Syst Biol Reprod Med. 2017. PMID: 28345956
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.Int J Mol Sci. 2020 Oct 31;21(21):8147. doi: 10.3390/ijms21218147. Int J Mol Sci. 2020. PMID: 33142702 Free PMC article. Review.
-
Follicular hyperandrogenism downregulates aromatase in luteinized granulosa cells in polycystic ovary syndrome women.Reproduction. 2015 Oct;150(4):289-96. doi: 10.1530/REP-15-0044. Epub 2015 Jul 21. Reproduction. 2015. PMID: 26199450
-
Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
Cited by
-
Investigation of FF-MAS oxysterole's role in follicular development and its relation to hedgehog signal pathway.Sci Rep. 2024 Oct 22;14(1):24863. doi: 10.1038/s41598-024-76281-5. Sci Rep. 2024. PMID: 39438722 Free PMC article.
-
Murine Models and Human Cell Line Models to Study Altered Dynamics of Ovarian Follicles in Polycystic Ovary Syndrome.Adv Biol (Weinh). 2025 Jul;9(7):e2400713. doi: 10.1002/adbi.202400713. Epub 2025 Jan 22. Adv Biol (Weinh). 2025. PMID: 39840999 Free PMC article. Review.
-
Editorial: Androgen receptors in male and female reproduction.Front Endocrinol (Lausanne). 2025 Jun 18;16:1638220. doi: 10.3389/fendo.2025.1638220. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40607217 Free PMC article. No abstract available.
-
Nicotinamide Mononucleotide Restores NAD+ Levels to Alleviate LPS-Induced Inflammation via the TLR4/NF-κB/MAPK Signaling Pathway in Mice Granulosa Cells.Antioxidants (Basel). 2024 Dec 31;14(1):39. doi: 10.3390/antiox14010039. Antioxidants (Basel). 2024. PMID: 39857373 Free PMC article.
-
Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome.Front Endocrinol (Lausanne). 2025 Mar 3;16:1523488. doi: 10.3389/fendo.2025.1523488. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40099263 Free PMC article.
References
-
- Ch M., Marshall J.C. Polycystic Ovary Syndrome. N. Engl. J. Med. 2016;375:1398–1399. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical